CHAMPIONS ONCOLOGY, INC. - 8-K Filing
Champions Oncology reports Q1 fiscal 2027 revenue of $15.2M with improved oncology services margin and adjusted EBITDA. (Items: 2.02 in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchan)
Tickers: $CSBR